Over the past 25 years the amount of data pertaining to the GABAergic function in the basal ganglia has increased dramatically. GABA and the Basal Ganglia - From Molecules to Systems is a comprehensive review of the current state-of-the-art of knowledge about the neuroanatomy, neuropharmacology and neurophysiology of the basal ganglia, focusing on its GABAergic microcircuitry. It serves as a complete reference to the body of knowledge about the basal ganglia, its constituent neurons, and their interconnections. This volume is designed to serve as a convenient all-in-one review and reference for experienced basal ganglia researchers as well as an introduction to the functional organization of the basal ganglia and its GABAergic circuitry for students and researchers new to the field. * Reviews the anatomy, physiology and pharmacology of the basal ganglia itself in addition to focusing on the GABAergic circuitry of the basal ganglia* Authors of each chapter leading internationally acclaimed experts in basal ganglia research
Inhaltsverzeichnis
1;Cover;1 2;Copyright page;5 3;List of Contributors;6 4;Preface;8 5;Contents;10 6;Section I: Fundamentals of GABA in the Basal Ganglia;12 6.1;Chapter 1. Basal ganglia macrocircuits;14 6.1.1;Acknowledgements;17 6.1.2;References;17 6.2;Chapter 2. GABA: Homeostatic and pharmacological aspects;20 6.2.1;GABA metabolism;20 6.2.2;GABA release and uptake;23 6.2.3;Pharmacology of metabolism and uptake;25 6.2.4;Concluding remarks;27 6.2.5;Acknowledgements;27 6.2.6;References;27 6.3;Chapter 3. GABAA receptors: structure and function in the basal ganglia;32 6.3.1;GABAA receptors: genes;33 6.3.2;GABAA receptor structure;34 6.3.3;GABAA receptor gating by agonist;36 6.3.4;Subunit assembly rules for GABAA receptors;37 6.3.5;Synaptic GABAA receptors: aß. subunit combinations and anchoring role of the .2 subunit and gephyrin;37 6.3.6;GABAA receptor occupancy at synapses is dynamic;38 6.3.7;Extrasynaptic GABAA receptors: a4ßd subtype;38 6.3.8;GABAA receptors: how subunit combinations affect synaptic and extrasynaptic transmission;39 6.3.9;GABAA receptor agonists, antagonists and allosteric modulators;40 6.3.10;Regulation of GABAA receptor function by neuromodulators: the role of kinases and phosphatases;43 6.3.11;Function and physiological significance of GABAA receptor diversity for the basal ganglia;44 6.3.12;Expression of GABAA receptor subunit genes in the basal ganglia;44 6.3.13;Acknowledgements;47 6.3.14;References;47 6.4;Chapter 4. GABAB receptors: structure and function;54 6.4.1;Introduction;54 6.4.2;Molecular characterization/structure;56 6.4.3;Pharmacology;62 6.4.4;References;65 6.5;Chapter 5. The cellular, molecular and ionic basis of GABAA receptor signalling;70 6.5.1;Introduction;70 6.5.2;Molecular basis of GABAA receptor function;71 6.5.3;Ionic permeability of GABAA receptors;73 6.5.4;GABAA receptor channel conductance;73 6.5.5;GABA concentration changes at the synapse;74 6.5.6;GABAA receptor gating and the IPSC;75 6.5.7;Tonic activity of GABAA receptors;77 6.5.8;Neurona
l ion regulation and the driving force for GABAA receptor-mediated currents;79 6.5.9;Neuronal chloride regulation;81 6.5.10;Neuronal pH regulation and EGABA;83 6.5.11;The developmental switch from depolarization to hyperpolarization;84 6.5.12;Ionic plasticity of GABAA receptor-mediated signalling;85 6.5.13;Ionic mechanisms of GABAergic inhibition in substantia nigra;86 6.5.14;Conclusion;87 6.5.15;References;88 7;Section II: GABAergic Microcircuits of the Basal Ganglia;100 7.1;Chapter 6. GABAergic inhibition in the neostriatum;102 7.1.1;Most striatal neurons are GABAergic, but most striatal synapses are not;102 7.1.2;Spatial distribution of GABAergic synapses on spiny cells;104 7.1.3;How can inhibition be effective when so outnumbered?;105 7.1.4;Feedforward and feedback inhibition;107 7.1.5;Winner-take-all inhibition in the striatum?;108 7.1.6;Could groups of spiny cells compete with each other?;109 7.1.7;Inhibition and the mechanism of up and down states in vivo;111 7.1.8;Why is Sp . Sp inhibition so weak?;113 7.1.9;The reversal potential of GABAA;115 7.1.10;Dendritic inhibition probably acts in the dendrites;118 7.1.11;References;118 7.2;Chapter 7. Globus pallidus external segment;122 7.2.1;Anatomical organization of the GPe;122 7.2.2;Physiologically distinct types of GPe neurons;123 7.2.3;Afferent projections of the GPe;123 7.2.4;Efferent projections of the GPe;125 7.2.5;Postsynaptic GABAergic responses;126 7.2.6;Presynaptic modulation;135 7.2.7;Metabotropic glutamate receptors;137 7.2.8;Postsynaptic modulations;138 7.2.9;Possible modulations by ambient GABA;138 7.2.10;GPe activity in patients and animal models of Parkinsons disease;138 7.2.11;Conclusions;139 7.2.12;Acknowledgments;139 7.2.13;References;139 7.3;Chapter 8. Globus pallidus internal segment;146 7.3.1;Introduction;146 7.3.2;Cellular types of GPi neurons;147 7.3.3;Basic circuitry of the GPi;147 7.3.4;Origin of GABA in the GPi;148 7.3.5;Localization of GABA receptors and transporters in the GPi;149 7.3.
6;GPi activity controlled by GABA;151 7.3.7;GPi activity during movements;153 7.3.8;GABA in the GPi and movement disorders;155 7.3.9;Conclusions;157 7.3.10;Abbreviations;157 7.3.11;Acknowledgments;157 7.3.12;References;158 7.4;Chapter 9. The pars reticulata of the substantia nigra: a window to basal ganglia output;162 7.4.1;Neuronal types;163 7.4.2;Cytoarchitecture and functional compartmentalization;164 7.4.3;Functional properties of SNr cells;168 7.4.4;The striatonigral input;170 7.4.5;The pallidonigral input;171 7.4.6;The subthalamonigral input;172 7.4.7;Local interactions between SNr cells;174 7.4.8;Regulation by neuromodulators;174 7.4.9;Conclusion and perspectives;175 7.4.10;References;175 7.5;Chapter 10. GABAergic control of the subthalamic nucleus;184 7.5.1;Introduction;184 7.5.2;Afferents of the STN;185 7.5.3;Electrophysiological properties of STN neurons;186 7.5.4;Principles of inhibitory synaptic integration in the STN;187 7.5.5;Enhancement of excitatory synaptic integration by GABAergic inhibition in the STN;191 7.5.6;Regulation of GABAergic inhibition in the STN by dopamine;193 7.5.7;Patterning of STN activity in vivo: proven and potential roles for GABAergic inhibition;195 7.5.8;Acknowledgements;197 7.5.9;References;197 7.6;Chapter 11. GABAergic control of substantia nigra dopaminergic neurons;200 7.6.1;Introduction;201 7.6.2;GABAergic synaptic responses in dopaminergic neurons;204 7.6.3;GABAergic inputs from the pars reticulata;209 7.6.4;Differences in GABAA responses between dopaminergic and GABAergic neurons;212 7.6.5;Conclusions;214 7.6.6;Acknowledgments;215 7.6.7;References;215 7.7;Chapter 12. GABAergic output of the basal ganglia;220 7.7.1;Outputs of the basal ganglia;220 7.7.2;An example of basal ganglia-controlled functions Saccadic eye movement;221 7.7.3;Functions of basal ganglia GABAergic outputs;224 7.7.4;Basal ganglia GABAergic control of basic movements;226 7.7.5;References;230 8;Section III: GABAergic Neurotransmission in the Basal Gangl
ia;238 8.1;Chapter 13. Localization of GABA receptors in the basal ganglia;240 8.1.1;Technical issues;241 8.1.2;Localization of GABA receptors in the striatum;243 8.1.3;Localization GABA receptors in the globus pallidus (internal and external);246 8.1.4;Localization GABA receptors in the substantia nigra;246 8.1.5;Localization GABA receptors in the subthalamic nucleus;251 8.1.6;Summary and conclusions;251 8.1.7;Acknowledgments;252 8.1.8;References;252 8.2;Chapter 14. Presynaptic modulation of GABA release in the basal ganglia;256 8.2.1;Introduction;256 8.2.2;Autoreceptors;257 8.2.3;Heteroreceptors;261 8.2.4;Retrograde signaling;263 8.2.5;Concluding remarks;266 8.2.6;Abbreviations;266 8.2.7;Acknowledgments;266 8.2.8;References;266 8.3;Chapter 15. Development of striatal fast-spiking GABAergic interneurons;272 8.3.1;Introduction;272 8.3.2;Electrophysiological properties of striatal fast-spiking GABAergic interneurons during postnatal development;273 8.3.3;Neurochemical control of striatal fast-spiking GABAergic interneuron development;279 8.3.4;Conclusions;281 8.3.5;Abbreviations;282 8.3.6;Acknowledgments;282 8.3.7;References;282 8.4;Chapter 16. Co-localization of GABA with other neuroactive substances in the basal ganglia;284 8.4.1;Location of neuropeptides and receptors in MSNs;284 8.4.2;Dopamine agonists increase neuropeptide expression in MSNs;286 8.4.3;Neuropeptide regulation of local striatal circuitry;287 8.4.4;Conclusion;291 8.4.5;Acknowledgment;292 8.4.6;References;292 9;Section IV: Systems Level Aspects of GABA in the Basal Ganglia;296 9.1;Chapter 17. GABAergic circuits in the basal ganglia and movement disorders;298 9.1.1;Anatomy and function of GABAergic circuits in the basal ganglia;298 9.1.2;Hypokinetic disorders;300 9.1.3;Hyperkinetic disorders;307 9.1.4;Conclusion;313 9.1.5;Abbreviations;313 9.1.6;References;314 9.2;Chapter 18. Simulation of GABA function in the basal ganglia: computational models of GABAergic mechanisms in basal ganglia function;324 9
.2.1;Introduction;324 9.2.2;Insights into inhibitory circuits from artificial neural networks;326 9.2.3;Challenges to the concept of lateral inhibition;328 9.2.4;Anatomy of spiny projection neuron interconnections in the striatum;329 9.2.5;Synaptic organisation of the neural network of the striatum: spinyspiny connections;330 9.2.6;Towards a realistic computational model of the spiny cell network;333 9.2.7;Results of the computer simulation;334 9.2.8;Other GABAergic computations in the striatum;336 9.2.9;Discussion;337 9.2.10;Acknowledgments;337 9.2.11;References;337 10;Subject Index;342